The consistent pattern of increased TNF-α, IL-6 and IL-17 levels supports the paradigm shift from viewing psoriasis as apurely cutaneous disease to recognizing it as a systemic immune-mediated disorder [14]. This evidence concerns the gene IL6 and psoriasis.